We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBAI
9526
Check-Cap
MBAI
$8.19M
-3
Closed -$9
CHH icon
9527
PUT
Choice Hotels
CHH
$5.07B
-15,000
Closed -$1.9M
CHR icon
9528
Cheer Holding
CHR
$3.47M
-9
Closed -$3.5K
CI icon
9529
PUT
Cigna
CI
$73.7B
-52,800
Closed -$19.2M
DCX
9530
Digital Currency X Technology Inc
DCX
$380M
0
-$2.2K
CLOA icon
9531
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$2.18B
-506
Closed -$26.2K
CLSD
9532
DELISTED
Clearside Biomedical
CLSD
-512
Closed -$11.7K
CMA
9533
PUT
DELISTED
Comerica
CMA
-25,000
Closed -$1.37M
CMCI icon
9534
VanEck CMCI Commodity Strategy ETF
CMCI
$2.92M
-2
Closed -$50
CMDT icon
9535
PIMCO Commodity Strategy Active Exchange-Traded Fund
CMDT
$803M
-241
Closed -$6.54K
CMDY icon
9536
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$557M
-672
Closed -$32.2K
CMS icon
9537
CALL
CMS Energy
CMS
$22.6B
-42,600
Closed -$2.57M
COCP icon
9538
Cocrystal Pharma
COCP
$11.3M
-20,258
Closed -$28.4K
COHR icon
9539
CALL
Coherent
COHR
$51.4B
-100,000
Closed -$6.06M
COIN icon
9540
PUT
Coinbase
COIN
$38.6B
-186,300
Closed -$49.4M
COM icon
9541
Direxion Auspice Broad Commodity Strategy ETF
COM
$205M
-53
Closed -$1.5K
COUR icon
9542
CALL
Coursera
COUR
$1.52B
-172,700
Closed -$2.42M
CPHI icon
9543
China Pharma Holdings
CPHI
$45M
-734
Closed -$2.72K
CPII icon
9544
Ionic Inflation Protection ETF
CPII
$11.3M
-73
Closed -$1.43K
CPNG icon
9545
PUT
Coupang
CPNG
$29.3B
-730,000
Closed -$13M
CRED
9546
DELISTED
Columbia Research Enhanced Real Estate ETF
CRED
-38
Closed -$804
CREVW
9547
DELISTED
Carbon Revolution PLC Warrant
CREVW
-36
Closed -$3
CREX icon
9548
Creative Realities
CREX
$41.1M
-802
Closed -$3.02K
CRGO icon
9549
Freightos
CRGO
$59.4M
-1,938
Closed -$4.75K
CRNX icon
9550
PUT
Crinetics Pharmaceuticals
CRNX
$8.84B
-20,000
Closed -$936K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.